Cargando…
A Shift Towards an Immature Myeloid Profile in Peripheral Blood of Critically Ill COVID-19 Patients
BACKGROUND: SARS-CoV-2, the etiological agent causing COVID-19, has infected more than 27 million people with over 894000 deaths worldwide since its emergence in December 2019. Factors for severe diseases, such as diabetes, hypertension, and obesity have been identified however, the precise pathogen...
Ejemplares similares
-
Increased expression of hypoxia-induced factor 1α mRNA and its related genes in myeloid blood cells from critically ill COVID-19 patients
por: Taniguchi-Ponciano, Keiko, et al.
Publicado: (2020) -
Molecular Alterations Prompted by SARS-CoV-2 Infection: Induction of Hyaluronan, Glycosaminoglycan and Mucopolysaccharide Metabolism
por: Andonegui-Elguera, Sergio, et al.
Publicado: (2020) -
Differences in mortality rate among patients hospitalized with severe COVID‐19 according to their body mass index
por: Albarrán‐Sánchez, Alejandra, et al.
Publicado: (2021) -
Real-world evidence of the use of glucocorticoids for severe
COVID-19
por: Albarrán-Sánchez, Alejandra, et al.
Publicado: (2022) -
Early Differentiation of Human CD11c(+)NK Cells with γδ T Cell Activation Properties Is Promoted by Dialyzable Leukocyte Extracts
por: Ramírez-Ramírez, Dalia, et al.
Publicado: (2016)